PHEnFX (TM), PHENO 550 mg, PHARMACEUTICAL GRADE, 90 CAPSULES, Manufactured for: Beta Labs, LTD, Newark, DE 19711
Recalling firm: Beta Labs
Why it was recalled
The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.
Check your package
Compare the exact product and package details with the label you have.
ProductPHEnFX (TM), PHENO 550 mg, PHARMACEUTICAL GRADE, 90 CAPSULES, Manufactured for: Beta Labs, LTD, Newark, DE 19711, UPC 029882559802
UPC029882559802
FDA code information
Lot # 1205129, Exp 12/16
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
PHEnFX (TM), PHENO 550 mg, PHARMACEUTICAL GRADE, 90 CAPSULES, Manufactured for: Beta Labs, LTD, Newark, DE 19711, UPC 029882559802
Extracted codes and context
| Type | Code / value | Context |
|---|---|---|
| UPC | 029882559802 | L GRADE, 90 CAPSULES, Manufactured for: Beta Labs, LTD, Newark, DE 19711, UPC 029882559802 |
| lot | 1205129 | Lot # 1205129, Exp 12/16 |
Recall details
- Recall number
- F-2400-2014
- Event ID
- 65585
- FDA status
- Terminated
- Initiated
- Jun 20, 2013
- Reported
- Sep 3, 2014
- Classified
- Aug 27, 2014
- Terminated
- Dec 3, 2014
- Quantity
- 743 units
- Location
- Memphis, TN, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Press Release
Where it was distributed
nationwide and UK
FDA source record · F-2400-2014
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.